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ABSTRACT 
 
We present an extremely rare case of Primitive Neuroectodermal tumor (PNET) / Ewing’s sarcoma of the prostate in 
a 40 years old Indian male who presented with pedal edema and dysuria. Ultrasonography was performed which 
showed a pelvic mass between urinary bladder and rectum. Fine Needle Aspiration Cytology diagnosis of a 
Malignant round cell tumor- PNET / Ewing’s sarcoma was made, which was confirmed by Biopsy and 
Immunohistochemistry (IHC). The prognosis of PNET / Ewing’s sarcoma of prostate is very poor since it is one of 
the most aggressive tumors and rare disease entity. To the best of our knowledge, this is the 10 
th
 case documented 
internationally and only second from Indian subcontinent. 
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Introduction 
Primitive Neuroectodermal tumor / Ewing’s sarcoma is 
mainly a tumor of the soft tissue or bone in children 
and young adults, although it occurs in all ages [1]. 
PNET of visceral organshave now been described. 
These tumors have a predilection for bone and soft 
tissues in the paraspinal region and lower extremities. 
[2]. Osseous and extraosseous Ewing’s sarcoma show 
the same chromosomal translocation t (11,22 ) (q24; 
q12)which allows the pathologists to identify 
immunohistochemically equivocal case.[3]. Various 
other translocation patterns may also be involved. [4]. 
PNET is divided into central PNET and peripheral 
PNET according to their location or origin. There are 
various symptoms in peripheral PNET which can occur 
in almost all areas of the body. A common feature of 
image findings of peripheral PNET is a large and 
infiltrative soft tissue mass with an ill defined , necrotic 
region and heterogenous enhancement. [5,6 ].Cases of  
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PNET occurring in visceral sites such as brain, parotid 
gland, lung, kidney, urinary bladder, uterus, pancreas, 
testes, ureter, seminal vesicles, stomach, omentum, 
ovary and rarely prostate. PNET of the prostate which 
was also classified as peripheral PNET, was first 
reported In 2003. We report a case of 40 years old 
Indian male diagnosed on cytomorphology and 
confirmed by histomorphology and 
Immunohistochemisrty.   
 
Case report 
 
A 40 years old Indian male patient presented with 
complaints of pedal edema and dysuria. 
Ultrasonography (USG) showed pelvic mass measuring 
6.2 x 5.6 cm between the urinary bladder and rectum. 
USG guided Fine needle aspiration cytology was done, 
cytomorphology of which showed bimodal population 
of round cells having coarse chromatin nucleus and 
vacuolated cytoplasm in large cells. Rosettes formation 
was seen. Background showed stripped nuclei. Hence 
the cytomorphological diagnosis of Malignant Round 
cell tumor – PNET / Ewing’s sarcoma was given. CT 
scan and MRI were done  after an interval of 7 days 
from initial diagnosis, which showed enlarged prostate 
gland measuring 11.5 cm (transverse) x 9.8 cm 
(Anteroposterior0 x 13.4 cm (supero-inferior), fairly 
defined, moderately enhancing, irregular shaped area 
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within the prostate. The residual prostatic gland were 
compressed to the periphery. No abdominal lymph 
nodes or invasion to adjacent organs was seen. No 
lesions were seen in liver, kidney, lungs or any other 
organ. S. PSA level was 1.0 ng/dl. 
 
 
 
Fig 1: Cytosmear, MGG stain, 40 x                    
 
 
 Fig 2: MRI-Lobulated heterogeneous masslesion 
[white arrow] which is hyperintense to  muscle on 
T2 W image seems to be arising from prostate 
[black arrow]. 
 
Further, core needle biopsy using 16 G biopsy gun 
under Ultrasonography guidance was done. 
Histomorphology of the sections showed round, 
uniform cells with scant clear cytoplasm, indistinct cell 
membranes, round nuclei with indentations, and an 
occasional mitotic figure. Rosettes were present. 
Histomorphological diagnosis of Malignant round cell 
tumor- PNET / Ewing’s sarcoma was thus made. 
Immunohistochemistry marker for CD 99 showed 
Diffuse membranous positivity. IHC markers for 
Synaptophysin, Chromogranin, LCA (CD 45), and 
PSA were Negative. Hence on the basis of 
cytomorphology, histomorphology and IHC markers 
diagnosis of PNET / Ewing’s Sarcoma of the prostate 
was confirmed. 
 
 
Fig3: Biopsy, H & E section , 10 X                                     Fig 4: Biopsy, H & E section, 40 X 
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Fig 5: CD 99- Diffuse membranous  positivity                      Fig 6: CD- 45, Negative 
 
Discussion 
 
PNET in the prostate is extremely rare, accounting for 
< 0.1 % of the primary prostate cancer types in adults. 
[7,8]. Common acinar prostatic adenocarcinoma 
accounts for 95 % of all malignant prostatic neoplasms. 
The diagnosis of PNET is based on cytological, 
histological examination. The main differential 
diagnosis considering the age of the patient and site of 
the tumor was Malignant Lymphoma which was easily 
ruled out due to negativity for CD 45. Strong diffuse 
membranous CD 99 positivity helped in establishing a 
diagnosis of primary PNET of the prostate. A 
multimodal therapeutic regimen that includes a 
combination of chemotherapy, surgery and 
radiotherapy is the current treatment strategy for the 
Ewing’s sarcoma family of tumors. PNET is 
radiosensitive tumor. In the present case which is 10
 th
 
in the series to be reported, the presentation was similar 
to all 9 cases reported earlier as PNET of the prostate 
gland. In all cases a large sized primary tumor replaced 
the prostate at the time of diagnosis. Despite the large 
size of the tumor in the pelvic area, the predominant 
complaint of the patient was the common symptom of 
dysuria. In all the 9 reported cases till date, patients 
were young adults (age range 20-31 years). Serum PSA 
was normal in all cases. Considering its rare occurrence 
the non specific imaging features of PNET , biopsy 
with IHC should be considered initially in case of 
delaying the illness, especially when there is a large 
retroperitoneal mass with aggressive characteristics. 
Conclusion 
 
PNET / Ewing’s sarcoma of the prostate is extremely 
rare. The data in the literature are also very scarce. 
PNET of the prostate gland should be considered when 
young male (20-40 years age) present to the hospital 
with the complaint of dysuria, to improve the rate of 
early diagnosis. FNAC helps in arriving at an early 
diagnosis with confirmation by histopahtological 
examination and IHC.As the prognosis is poor, utmost 
attention must be made in differentiating the tumor 
from other round cell tumors and to the treatment. 
Summarising the case report , the present case of 
primary PNET of the prostate is 10 th case in the series 
to be reported internationally and only 2 nd from 
Indian subcontinent [9] in an Indian adult male patient 
aged 40 years. 
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